Intended Use

HeartFlow FFRCT is a post-processing software for the clinical quantitative and qualitative analysis of previously acquired Computed Tomography DICOM data for clinically stable symptomatic patients with coronary artery disease. It provides FFRCT, a mathematically derived quantity, computed from simulated pressure, velocity and blood flow information obtained from a 3D computer model generated from static coronary CT images. FFRCT analysis is intended to support the functional evaluation of coronary artery disease.

Technology

HeartFlow FFRCT analyzes CT DICOM cardiac images using a 3D computer model to simulate pressure, velocity and blood flow generating fractional flow reserve (FFRCT). It is vendor and imaging equipment independent, performing post-processing analysis only.

Performance

HeartFlow FFRCT was validated through clinical studies comparing FFRCT results to invasive fractional flow reserve (FFR). The HeartFlowNXT study showed good sensitivity (~84%) and specificity (~85%) in detecting hemodynamically significant coronary lesions. Software was tested for repeatability, and clinical validation ensured safety and effectiveness with no adverse patient effects.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    9/22/2015

    3 months
  • 2

    FDA Approval

    1/13/2016

Other devices from HEARTFLOW, INC.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.